the Go or G1 phases of the cell cycle is a sharp emission polarization peak at 510 nm which disappears on their progression into the DNA-synthesis phase (Cercek et al., 1973 (Cercek et al., , 1978 . Recently, it has been established that changes in this emission polarization peak reflect alterations in the structuredness of the mitochondria as a result of their transition from the condensed to the orthodox conformation and vice versa. The formation and disappearance of the emission polarization peak at 510 nm (P510-peak) is therefore a marker for the conformational changes in the mitochondria in intact cells (Cercek & Cercek, 1979) .
We have reported that quantitative changes in the intracellular fluorescein fluorescence polarization of haemopoietic cell lines treated with proliferation-inhibiting cell extracts can be used to study the specificity and reversibility of the effects of these substances (Lord et al., 1974a, b) . To qualify the changes induced by these growth inhibitors we have now studied the effects of lymph-node extracts (LNE), granulocytic extracts (GCE) and red-cell extracts (RCE) on fluorescein emission polarization spectra of lymphocytes and the precursor cells of granulocytes and red cells. The aim of this study was to establish whether the growthinhibiting effects of these extracts could be linked to the induction of structural changes in the mitochondria (SCM).
Details of the technique for measurement of the fluorescein fluorescence polarization spectrum in living cells (Cercek et al., 1978) as well as the preparation of the LNE (Houck et al., 1971; Lord et al., 1974a) , GCE (Rytomaa & Kiviniemi, 1968; Lord et al., 1974a) and RCE (Kivilaakso & Rytomaa, 1971; Lord et al., 1974a) extracts were the same as described before. The haemopoietic cells used were human peripheral SCM-responding lymphocytes (Cercek et al., 1978) , mouse femoral marrow cells and regenerating spleen cells. Details of the preparation of these cells were given previously (Lord et al., 1974a) .
To test the LNE, SCM-responding lymphocytes, which are normally in the Go or G1 phase of the cell cycle, were first incubated with phytohaemagglutinin (PHA). These stimulated lymphocytes were used as controls (Lord et al., 1974a, b) . The GCE was tested on mouse femoral marrow cells, of which -35% were proliferating granulocytic cells. Since marrow also contains erythrocyte precursor cells, the RCE was also tested on these cells. In addition, RCE was tested on the rapidly proliferating erythrocyte precursors found in the spleens of heavily irradiated mice 7 days after grafting with 106 normal marrow cells (regenerating spleens). The doses of LNE, GCE and RCE were the same as those used in the earlier fluorescence studies (Lord et al., 1974a, b) and in cell-proliferation studies (Lord, 1975; Lord et al., 1977) i.e. 50 pg/ml of cell suspension. As shown in Fig. 1 , the fluorescein emission polarization spectra of the asynchronous populations of mouse marrow cells, regenerating spleen cells and human PHA-stimulated lymphocytes, do not exhibit a polarization peak at 510 nm indicating that most of their mitochondria are in the condensed conformation (Cercek & Cercek, 1979 absence of the P510 peak in asynchronous populations appears to be due to an activator produced by S-phase cells. However, when these cells were incubated for 45 min at 37°C with the growthinhibiting extract specific for the cell type tested (LNE, GCE or RCE) the respective fluorescein emission polarization spectra exhibited the sharp P510 peak. Since both GCE and RCE are shown to be cell-line specific, their respective net effects on the fluorescence polarization spectra for normal marrow must be expected to be less than if they were tested on pure populations of granulocytic or erythroid cells. Thus, the ratio of the polarization values at 510 and 515 nm is very much smaller for whole marrow (Fig. IC) than for the population in regenerating spleen (Fig. IA) Fig. 2 confirms that decreases in intracellular water induce only wavelength-independent changes in the emission polarization spectrum. No sharp peak at 510 nm appears, which contrasts with the effect of growth inhibitors (Fig. 1) . These results indicate that the specific haemopoietic growth inhibitors induce in the fluorescein emission polarization spectra of their precursor cells qualitative wavelength-dependent changes which are compatible with structural changes in the mitochondria, viz. the transition into their orthodox, idling-state conformation. Since the transition to the orthodox conformation is usually accompanied by a decrease in the rate of ATP production, these effects of growth inhibiting extracts on the structuredness of the energyproducing domain appear to be involved in the inhibitory and/or delaying effects of the "chalones" on cell proliferation: reduced labelling index, reduced flow through the cell cycle, prolonged G1, reduced cell production etc. (Houck et al., 1973; Houck & Attalah, 1975; Lord, 1975; Lord et al., 1977) . The detailed mechanism by which these cell-specific growth inhibitors induce structural changes in the mitochondria has to be investigated. It has been shown on isolated mitochondria in the orthodox conformation and oni normal synchronized cells in GU that addition of 10-4M of ATP, ADP, succinate (substrate) or pyruvate, (precursor substrates) of the tricarboxylic acid (TCA) cycle induce the disappearance of the 510 nm peak (Cercek & Cercek, 1979) indicating the transition of mitochondria into the switched-on, condensed conformation (Lehninger, 1975; Loewy & Siekevitz, 1974) . As shown in Table I , the GCE-, RCE-and LNE-induced 510 nm peak in the emission polarization spectra of the respective precursor cell lines can also be abrogated by the above substances. Furthermore, the presence of substances which do not revert the mitochondria into the orthodox conformation, but are known to uncouple the electron-transport chain and/or oxidative phosphorylation (e.g. 10-7M dinitrophenol (DNP) and 10-4M oligomycin, respectively (Lehninger, 1975)) prevents the induction of the 51Onm peak by GCE, RCE or LNE (Table II) . These results show that interference with the TCA cycle prevents the transition of mitochondria by the above growth inhibitors into the orthodox conformation. However, the present data do not allow us to decide whether the effects of these growth inhibitors are caused by a selective uptake into the respective precursor cells followed by direct effects on the structural changes in the mitochondria, thereby affecting the rate of ATP production, or by other indirect processes such as modulation of the adenylcyclase-phosphodiesterase system (Houck & Attalah, 1975) .
Interference with the adenylcyclase-phosphodiesterase system has been shown before to induce changes in SCM (Cercek & Cercek, 1974) . Another tentative explanation for the effect of the growth inhibitors on SCM could be that a direct inhibition of DNA synthesis by chalones (Houck et al., 1973; Houck & Attalah, 1975; Lord, 1975; Lord et al., 1977 ) might simultaneously stop the production of the mitochondrial activator. Consequently, the mitochondria of G1 cells in the asynchronous population would revert to the orthodox conformation, as reflected in the P510 peak. However, more experiments are needed to support any of the above hypotheses.
In conclusion, changes induced by the specific haemopoietic growth inhibitors in the fluorescence emission polarization spectra of their respective precursor cell lines indicate that their inhibitory effects on cellular processes are accompanied by transient and reversible changes of the mitochondria into the orthodox conformation, which thereby might modulate the rate of ATP production in these cells.
